For more information, contact:
Karen McNulty Walsh, 631 344-8350
Mona S. Rowe, 631 344-5056

go to home page

November 19, 2002

Electronic newsroom

02-83

 

Scientists Reveal a New Way Viruses Cause Cells to Self-Destruct

UPTON, NY -- Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and their collaborators have discovered that some viruses can use the most abundant protein in the cells they are infecting to destroy the cells and allow new viruses to escape to infect others. The findings, described in the November 29, 2002, issue of the Journal of Biological Chemistry, build upon earlier Brookhaven research on how virus particles become infectious (see related story)  and may lead to the design of more effective antiviral remedies.

"This is a new and philosophically interesting way for a virus to escape from cells," said Brookhaven biologist Walter Mangel, a coauthor on the paper. "In essence, a protein in the infected cells can serve as the seed of the cellsí own destruction."

Mangel's group has previously shown that adenovirus -- a virus that causes respiratory and gastrointestinal infections and also conjunctivitis -- produces a protein-cleaving enzyme, or protease, to complete the maturation of newly synthesized virus particles. Similar to the way supportive scaffolding is removed after the completion of a construction project, this protease cleaves, or cuts out, viral "construction" proteins, leaving infectious virus particles behind.

This viral protease is produced in the cytoplasm in an inactive form, and must migrate to the nucleus to become activated in newly synthesized viral particles by two viral cofactors. Once activated, it can cleave several viral proteins to complete the viral maturation process. There were no indications that the protease could be activated in the cellís cytoplasm.

When Mangel presented this research at a seminar at Princeton University, Clarence Schutt, a Princeton chemistry professor, pointed out that the amino acid sequence of one of the viral cofactors was dramatically similar to the sequence of actin, a cytoplasmic protein that gives shape and structure to cells. Mangel wondered if actin could activate the protease, and took some from Schutt's lab back to Brookhaven to do the experiment.

This ribbon diagram is a theoretical representation of the structure of adenovirus protease (red) bound to the cytoskeleton protein actin (green). The blue, green, and yellow balls show the location of the active site of the adenovirus protease.
 

The result: Incubating actin and the adenovirus protease increased the cleaving ability of the protease, just like the viral cofactor did, allowing the actin-protease complex to cleave actin itself, as well as other cellular skeleton proteins.

"When actin and other cytoskeleton proteins are destroyed," Mangel explained, "a cell loses its shape and eventually breaks open, allowing the newly synthesized virus particles to escape and infect other cells."

The same two cells were photographed to show the location of the adenovirus protease (labeled with a green fluorescent molecule) and the cytoskeleton protein cytokeratin 18 (labeled with a red fluorescent molecule). The adenovirus protease is known to cleave cytokeratin 18 (as well as other cytoskeletal proteins), and this experiment shows they are located at the same sites within the cells.
 

While other viruses are known to cleave actin and other cytoskeleton proteins as a means of breaking free to continue infection, none of them is known to use actin as a cofactor in this process, Mangel said. "Thus, the really interesting finding in this case is that actin is a cofactor for its own destruction," Mangel said.

The next step for Mangel's group will be to crystallize complexes of actin bound to the adenovirus protease to determine its atomic structure at the National Synchrotron Light Source at Brookhaven.

"The structure would then be used to find drugs to prevent the interaction between actin and the adenovirus protease," Mangel said. "Such drugs could serve as a new type of antiviral agent."

This work was done in collaboration with Mark Brown, Kevin McBride, Mary Lynn Baniecki, and Nancy Reich of Stony Brook University and Gerard Marriott of the University of Wisconsin. It was funded by the U.S. Department of Energy, which supports basic research in a variety of scientific fields, and the National Institutes of Health.

The U.S. Department of Energy's Brookhaven National Laboratory conducts research in the physical, biomedical, and environmental sciences, as well as in energy technologies. Brookhaven also builds and operates major facilities available to university, industrial, and government scientists. The Laboratory is managed by Brookhaven Science Associates, a limited liability company founded by Stony Brook University and Battelle, a nonprofit applied science and technology organization.